Aprepitant, a novel neurokinin-1 receptor antagonist in management of chemotherapy induces nausea vomiting (CINV) in cancer patients. (2019). International Journal of Research in Clinical and Hospital Pharmacy, 2(1), 1-4. https://rubatosis.org/journals/index.php/ijrhcp/article/view/144